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Novel mutant green fluorescent protein protease substrates 
reveal the activation of specific caspases during apoptosis 
Nupam P Mahajan 1, D Corinne Harrison-Shostak 1, Jennifer Michaux 1 
and Brian Herman 1,2 
Background: The caspase-mediated proteolysis of many cellular proteins is a 
critical event during programmed cell death or apoptosis. It is important o 
determine which easpases are activated in mammalian cells, and where and 
when activation occurs, upon receipt of specific death stimuli. Such information 
would be useful in the design of strategies to regulate the activation of 
easpases during apoptosis. 
Results: We developed two novel fluorescent substrates that were specifically 
cleaved by caspase-.1 or caspase-3. For in vitro studies, four-amino-acid 
recognition sequences, YVAD for caspase-1 and DEVD for caspase-3, were 
introduced between blue fluorescent protein (BFP) and green fluorescent 
protein (GFP), expressed in bacteria and purified. For in vivo studies, YVAD and 
DEVD were introduced between cyan fluorescent protein and yellow 
fluorescent protein, and expression was monitored in live mammalian cells. The 
proximity between fluorophores was determined using fluorescence resonance 
energy transfer. Purified substrates w re cleaved following exposure to purified 
caspase-1 and caspase-3. In Cos-? cells, caspase-1 and caspase-3 substrates 
were cleaved upon induction of apoptosis with staurosporine, a protein-kinase 
inhibitor, whereas caspase-3 but not caspase-1 substrate was cleaved upon 
treatment of cells with the DNA-damaging agent mitomycin . 
Conclusions: These substrates allow the spatial activation of specific members 
of the caspase family to be deciphered during the initiation and execution phase 
of programmed cell death, and allow activation of specific caspases to be 
monitored both in vivo and in vitro. This technology is also likely to be useful for 
high-throughput screening of reagents that modulate caspase activity. 
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I n t roduct ion  
Apoptosis or programmed cell death is a normal physiologi- 
cal process of cell suicide, which is of crucial importance for 
the development and maintenance of all multicellular 
organisms. It can be initiated by many different stimuli 
such as withdrawal of growth factors, DNA damage and 
binding of certain ligands to cell-surface receptors. Muta- 
tion studies carried out in the nematode Caenorhabditis 
elegans led to the identification of the ced-3 gene as essential 
for programmed cell death [1]. Later, the protein encoded 
by ced-3 was identified to be a mammalian homolog of inter- 
leukin-l~-converting enzyme (ICE) [2], which has been 
shown to be a member of a family of cysteine proteases 
termed caspases (for cysteinyl aspartate-specific proteinase) 
[3]. ICE (also called caspase-1) and other members of this 
family share an absolute requirement for aspartic acid in the 
P1 position of their substrates [4]. Caspase-1 is expressed as 
an inactive 45 kDa precursor in resting cells, but during 
apoptosis it is cleaved to form two subunits of 10 and 
20 kDa that together constitute active protease [5]. The cat- 
alytically active form of caspase-1 is a tetramer consisting of 
a (p20-pl0) z homodimer that cleaves the 31 kDa IL-113 pre- 
cursor (pro-IL-1[3) at Aspl l6-Alal l7 to generate the 
17.5 kDa mature form of IL-113 [6]. Similarly, YAMA, or 
caspase-3, has been shown to be expressed as a 32 kDa pre- 
cursor that is cleaved into 17 and 12 kDa subunits upon 
initiation of apoptosis by various death stimuli [7]. 
Activated caspases not only cleave other pro-caspases, but 
also cleave and inactivate various essential cellular pro- 
teins, as well as DNA, through activation of specific 
deoxyribonucleases called CAD [8]. Caspases have dis- 
tinct preferences for their substrates. Caspase-3 cleaves 
the DNA-repair enzyme poly (ADP-ribose) polymerase 
(PARP) into signature apoptotic fragments [7,9], whereas 
lamin A is cleaved by caspase-6 (Mch2~) and not by 
caspase-3 [10]. The location of caspases within viable cells 
and their redistribution upon induction of apoptosis has 
also been studied. The precursor of caspase-3 has been 
shown to be localized in mitochondria nd cytoplasm in 
normal cells but, in the presence of apoptotic stimuli, it is 
lost from mitochondria [11]. 
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Figure I 
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The principle of measuring caspase activity 
using FRET. Two mutant GFP molecules (BFP 
and GFP or CFP and YFP) are joined by a 
short peptide bridge containing either an ICE 
(caspase- 1 )- or YAMA (caspase-3)-specific 
cleavage site. (a) When the mutant GFPs (in 
the case illustrated here) CFP and YFP are 
within 10-100/~ of one another and excitation 
energy is supplied at the maximum 
absorbance of the donor (CFP, 433 nm), CFP 
can transfer its excitation energy nonradiatively 
to the acceptor (YFP), which will fluoresce at 
its emission maximum (528 nm). When 
caspases are activated, the link between these 
two mutant GFPs is broken and the distance 
between them increases to > 100 ,~,, resulting 
in a loss of measurable FRET. (b) BFP/GFP 
ICE (blfs) and YAMA (bYfs) FRET caspase 
substrates. Also shown are CFP/YFP ICE 
(mlfs), YAMA (mYfs) and nonspecific glycine 
(mGfs) substrates. 
Green fluorescent protein (GFP), a protein of 238 amino 
acids and -27 kDa, has been used extensively to deter- 
mine the localization of various proteins in many mam- 
malian and other eukaryotic ells [ 12-14]. Mutants of GFP 
with enhanced emission and altered excitation a d emis- 
sion properties have been used effectively to monitor the 
movement of proteins [14-15] and protein-protein i ter- 
actions [12] in live mammalian cells. Two different 
mutants of GFP, Ser65--+Tyr ($65T), which emits bright 
green fluorescence with an excitation peak of 489 nm and 
an emission peak of 511 rim, and BFP, a blue fluorescent 
protein that has excitation and emission peaks of 389 nm 
and 445 nm, respectively, have been used recently to 
examine protein-protein teractions in vivo [12,14] using 
fluorescence resonance nergy transfer (FRET). Another 
set of GFP mutants has recently been identified - - cyan  
fluorescent protein (CFP) and yellow fluorescent protein 
(YFP) [16]- - that  can also be used to examine 
protein-protein teractions or changes in protein confor- 
mation in vivo. The combination of BFP-GFP or 
CFP-YFP fluorophores can be used for FRET studies as 
the emission spectrum of BFP/CFP (donor) overlaps the 
excitation spectrum of GFP/YFP (acceptor; Figure la) 
[12,16-17]. Following excitation f the donor (BFP/CFP), 
its excitation energy can be transferred nonradiatively to 
the acceptor (GFP/YFP), if the distance separating these 
two molecules is between 10 and 50 A. 
We have employed a novel strategy to study the activa- 
tion of specific caspases in live mammalian cells (see 
Figure la). The fluorescent substrates are designed in 
such a way that the two fluorophores (BFP and GFP or 
CFP and YFP) are linked physically via a four-amino- 
acid caspase-recognition sequence (Figure la,b). In the 
present study, fluorescent substrates bYfs (bacterially 
expressed YAMA-specific fluorescent substrate) andblfs 
(bacterially expressed ICE-specific fluorescent sub- 
strate) were expressed in bacteria by employing the 
BFP-GFP pair, whereas in mammalian cells the 
CFP-YFP pair was used for the synthesis of fluorescent 
substrates mlfs (mammalian ICE specific fluorescent 
substrate), mYfs (mammalian YAMA-specific fluorescent 
substrate) and mGfs (mammalian glycine-containing flu- 
orescent substrate; Figure lb). 
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Figure 2 
Western blot and FRET analysis of caspase 
activity in vitro. An anti-GFP monoclonal 
western blot demonstrating purified BFP/GFP 
ICE (blfs) and YAMA (bYfs) substrates, either 
(a) alone or (b) following 12 h exposure to 
purified ICE or YAMA caspases. (c) FREq" 
photon emission from purified BFP/GFP ICE 
(blfs) and YAMA (bYfs) substrates, either 
alone or following 12 h exposure to purified 
ICE or YAMA caspases. A decrease in FRET, 
measured as described in Figure 1, indicates 
caspase-mediated cleavage of the mutant 
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In mammalian cells, upon excitation at -433 nm, a signifi- 
cant increase in emission (due to FRET)  at -528 nm 
would occur only if the two fluorophores CFP and YFP are 
within 10-50A of one another or linked physically 
together by the four-amino-acid bridge. Upon treatment 
with different apoptosis-inducing a ents, cells would acti- 
vate different members of the caspase family, resulting in 
cleavage of the respective fluorescent substrates within 
the four-amino-acid recognition sequence. This would 
result in a separation of the two fluorophores leading to a 
decrease in FRET.  Similarly, purified fluorescent sub- 
strates bYfs and bIfs (Figure lb) would have significant 
emission (FRET) at -511 nm upon excitation at -389 nm 
because the two fluorophores BFP and GFP are essentially 
linked via a four-amino-acid caspase-recognition sequence. 
Following digestion with purified caspases, there would be 
a decrease in FRET  emission. Here we demonstrate that 
FRET  emission from purified fluorescent substrates was 
decreased upon digestion with caspase-1 and caspase-3. 
Similarly, treatment of mammalian cells with staurosporine 
and mitomycin c resulted in a significant caspase-specific 
decrease in FRET  emission, suggesting that specific cas- 
pases are activated uring apoptosis. 
Resu l ts  
Purif ication of GFP-BFP  f luorescent substrates and FRET 
measurement  
Two recombinant fluorescent substrates blfs and bYfs 
were expressed in bacterial cells in which four-amino-acid 
recognition sequences for caspase-1 (YVAD) or caspase-3 
(DEVD) were sandwiched between GFP and BFP mole- 
cules (Figure lb). These fluorescent substrates were puri- 
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Figure 3 
Transient in vivo expression of CFP, YFP, mYfs, mlfs and mGfs in Cos-7 
cells. Expression of either (a) CFP or (b) YFP results in diffuse cytosolic 
distribution. In approximately 50% of cells, expression of mYfs, mlfs or 
mGfs resulted in a diffuse distribution similar to that seen in (a) and (b). 
In the rest of the cell population, (e) mYfs, (d) mlfs and (e) mGfs 
accumulated into cytosolic vesicular structures of unknown identity. 
fied and separated on sodium dodecyl sulfate-polyacry- 
lamide gel electrophoresis (SDS-PAGE) gels, and ana- 
lyzed using western blotting. On hybridizing the blots 
with anti-GFP monoclonal antibodies, bands of 55 kDa 
corresponding to bits and bYfs were detected, which con- 
firmed that intact fluorescent substrates had been isolated 
(Figure 2a). To verify the susceptibility of blfs and bYfs to 
caspases, an excess of purified blfs or bYfs was incubated 
with purified caspase-1 (Figure 2b, lanes 2 and 3) or 
caspase-3 (Figure2b, lanes 5 and 6) for 12 h. Incubation 
with their respective caspases resulted in the digestion of 
55 kDa caspase-1- and caspase-3-specific fluorescent sub- 
strates into 27 kDa cleavage products (Figure 2b, lanes 2 
and 5). To confirm that the cleavage of 55 kDa blfs and 
bYfs into two subunits of 27 kDa each was reflected in a 
change in FRET  signal, emission of photons from the 
digested, as well as the undigested, blfs and bYfs was 
measured. As expected, the cleavage of blfs and bYfs was 
associated with a decrease in FRET signal (Figure 2c). 
The in vitro cleavage of blfs and bYfs was inhibited by the 
pan-caspase inhibitor z-Val-Ala-Asp-fluoromethylketone 
(zVAD-fmk; Figure 2b,c). 
Expression of CFP-YFP fluorescent substrates in 
mammalian cells 
For expression in mammalian cells, we chose CFP and 
YFP instead of BFP and GFP (Figure lb). CFP and YFP 
are humanized versions of GFP whose excitation and 
emission spectra are red-shifted relative to BFP and 
GFP, and they are therefore considerably brighter in 
mammalian cells. Three amino-acid recognition 
sequences, YVAD (for caspase-1), DEVD (for caspase-3) 
and GGGG (control), were introduced between CFP and 
YFP to create three fluorescent substrates called mils, 
mYfs and mGfs, respectively (Figure lb). mGfs was used 
as a control fluorescent substrate because to our knowl- 
edge there is no caspase in cells that has a recognition 
sequence of four glycine residues. Cos-7 cells trans- 
fected with constructs expressing CFP, YFP or mGfs flu- 
orescent substrates demonstrated uniform distribution of 
fluorescence in -50% of cells (Figure 3a,b,e). Although 
approximately 50% of mils- and mYfs-expressing cells 
had a uniform distribution of fluorescence in cells identi- 
cal to mGfs, the rest of the cells demonstrated fluores- 
cence in spherical vesicles, which were predominantly 
localized in the cytoplasm and rarely in nuclei 
(Figure 3d,e). 
To determine if Cos-7 cells undergo apoptosis upon 
treatment with death-inducing agents, cells were treated 
with the protein-kinase inhibitor staurosporin and the 
DNA-damaging agent mitomycin c. It has been amply 
demonstrated that induction of apoptosis leads to the 
cleavage of the endogenous death substrate PARP [7,9]. 
Cells were treated with staurosporin and mitomycin c and 
western blot analysis was performed using anti-PARP 
monoclonal antibody. Staurosporin treatment for 5 h 
resulted in cleavage of the majority of 116 kDa PARP 
into a characteristic 85 kDa fragment (Figure 4a, lane 2), 
whereas mitomycin treatment for 5 h resulted in consid- 
rably less cleavage (Figure 4a, lane 3). This clearly indi- 
cates that both staurosporin and mitomycin c induce 
apoptosis in Cos-7 cells, which can be seen as signature 
cleavage of PARP. 
Commonly used synthetic fiuorogenic substrates 
YVAD-AMC and DEVD-AMC were employed to verify 
the specificity of the caspases upon induction of apoptosis 
(Figure 4b,c). The fluorogenic substrate YVAD-AMC is 
specifically cleaved by caspase-1, whereas members of the 
caspase-3 subfamily cleave DVED-AMC. YVAD-AMC or 
DEVD-AMC was incubated with extracts of cells treated 
with apoptotic agent staurosporin or mitomycin c for 5 h. 
Incubation of the substrates with an extract of cells treated 
with mitomycin c resulted in cleavage of DEVD-AMC 
(Figure 4b), but not YVAD-AMC (Figure 4c). Stauro- 
sporine treatment herefore led to activation of both 
caspase-1 and caspase-3 subfamily members, whereas mit- 
omycin c treatment led to activation of members of the 
caspase-3 subfamily. 
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(a) 
Induction of apoptosis upon treatment of Cos-7 
cells with apoptosis-inducing agents. 
(a) Measurement of endogenous caspase 
activity. Cos-7 cells were treated with 
staurosporin or mitomycin c for 5 h and western 
analysis was performed using anti-PARP 
antibodies. The 116 kDa endogenous PARP is 
cleared into an 85 kDa fragment. (b) The 
cleavage of caspase-1-specific synthetic 
fluorescent substrate YVAD-AMC, on treatment 
with staurosporine (STS) and mitomycin c
(MMC) for 5 h. An increase in optical density 
indicates production of AMC fluorescence due 
to cleavage of the synthetic fluorescent 
substrate. (c) The cleavage of caspase-3- 
specific synthetic fluorescent substrate DEVD- 
AMC, on treatment with staurosporine and 
mitomycin c for 5 h. (d) Induction of apoptosis 
in cells expressing (i) mlfs, (iii) mYfs and (v) 
mGfs as seen by disintegration of nuclei by 
DAPI staining (ii, iv and vi). 
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It was important o determine if the distribution of the 
three fluorescent substrates was affected when cells 
undergo apoptosis. Cos-7 cells expressing mlfs, mYfs or 
mGfs were treated with staurosporine for 5 h. Cell nuclei 
were stained with the DNA-binding stain DAPI for visual- 
ization of fragmentation f nuclei, a hallmark of apoptosis 
(Figure 4d, panels ii, iv and vi). All of the three fluorescent 
substrates were uniformly distributed throughout the cells 
during apoptosis (Figure 4d, panels i, iii and v). The pro- 
portion of cells undergoing apoptosis after a 5 h treatment 
with staurosporin was found to be -63% as visualized by 
fragmentation f nuclei. 
Cleavage of CFP-YFP  f luorescent substrates during 
apoptosis 
To determine if the fluorescent substrates mIfs, mYfs and 
mGfs are cleaved in mammalian cells upon receipt of a 
death stimulus, Cos-7 cells were treated with the protein- 
kinase inhibitor staurosporine and the DNA-damaging 
agent mitomycin c. Treatment of cells with staurosporin 
for 5 h resulted in cleavage of 55 kDa mils and mYfs into 
27kDa fragments corresponding to CFP and YFP 
(Figure 5a,b, lane 3). Similar treatment did not bring 
about cleavage of 55 kDa mGfs into 27 kDa fragments or 
iv) 
further cleavage of 27 kDa CFP into smaller fragments 
(Figure 5c,d, lane 3). Addition of zVAD-fmk, a broad spec- 
trum, cell permeable, tripeptide inhibitor of caspases, in 
cell-growth medium resulted in complete repression of 
the cleavage of mlfs and mYfs into 27 kDa fragments 
(Figure 5a,b, lane 5). This indicates that staurosporine 
treatment results in activation of both caspase-1 and 
caspase-3, which cleave at the recognition sequence to 
produce two fragments of-27 kDa each. 
To determine whether specific caspases are activated 
upon the induction of apoptosis by a DNA-damaging 
agent, cells were treated with mitomycin c for 5 h, and 
analyzed using western blotting. None of the fluorescent 
substrates was cleaved to form of 27 kDa cleavage 
product (Figure 5a,b,c,d, lane 2), indicating that 5 h of 
mitomycin c treatment does not result in the activation of 
either caspase-1 or caspase-3. To determine whether a 
longer duration of mitomycin c treatment is required to 
activate caspases, mlfs-, mYfs- and mGfs-expressing cells 
were treated with mitomycin c for 12 h, and analyzed 
using western blotting (Figure 5e). Cleavage of the 
55 kDa substrate occurred in mYfs-expressing cells, 
whereas the 27kDa product was not observed in 
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Activation of specific caspases upon 
induction of apoptosis with DNA-damaging 
agents. (a.b,c,d) Cells were treated with 
mitomycin c for 5 h, and analyzed using 
western blotting. (e) Cells were treated with 
mitomycin c for 12 h and analyzed using 
western blotting. (f) Cells treated with 
etoposide, another DNA-damaging agent. 
mlfs- and mGfs-expressing cells upon a longer duration 
of mitomycin c treatment (Figure 5e). As a control, the 
cells were treated with etoposide, another DNA-damag- 
ing agent (Figure 5f). Treatment with etoposide for 12 h 
did not result in the formation of the 27 kDa product. 
The exposure of cells to mitomycin c for 12 h therefore 
led to activation ofcaspase-3 but not caspase-1. Etoposide 
treatment for 12 h did not bring about activation of 
caspase-1 or caspase-3 (Figure 5f). 
Measurement of FRET 
To determine if the induction ofapoptosis in cells was fol- 
lowed by a change in the FRET signal of the fluorescent 
substrates mlfs, mYfs and mGfs, Cos-7 cells were treated 
with staurosporin and mitomycin c for 8-10 h. Cells were 
washed and the emission of photons from live cells was 
measured using the FRET filter set. Cells expressing mlfs 
and mYfs demonstrated 33and 36% decrease in emission 
of photons on treatment with staurosporin, respectively 
(Figure 6). The photon emission from cells expressing 
mGfs and CFP remained unchanged (Figure 6). Similarly, 
cells expressing mYfs demonstrated a ecrease of -34% in 
emission of photons on treatment with mitomycin c, 
whereas photon emission from cells expressing mlfs, 
mGfs and CFP remained unchanged (Figure 6). Addition 
of zVAD-fmk to cells treated with staurosporin and mito- 
mycin c demonstrated an increased emission of photons, 
similar to that of untreated cells, indicating a lack of cleav- 
age of the substrates. 
Discuss ion  
Activation of specific caspases is a critical element of 
apoptotic process. Induction of apoptosis by specific 
death stimuli leads to the activation of distinct sets of cas- 
pases. Here, we demonstrate the design of GFP-based 
caspase tetrapeptide recognition sequence containing 
substrates (GTRCOSs), which were cleaved upon induc- 
tion of cell death. This strategy not only enabled us to 
monitor the activation of particular caspases upon induc- 
tion of cell death with specific death stimuli, but also 
allowed us to monitor caspase activation in live mam- 
malian cells. In addition, large-scale purification of these 
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fluorescent substrates made it possible to confirm the 
presence of activated caspases in vitro. 
Caspase-3 has been reported to become activated upon 
staurosporine treatment of GM701 cells [18]. The activa- 
tion of caspase-3 was monitored by cleavage of its sub- 
strate PARP; this cleavage was shown to be inhibited by 
zVAD-fmk and overexpression f Bcl-2 [18]. Furthermore, 
it was demonstrated that Rat-1 cells expressing the 
caspasc-1 inhibitor CrmA were as sensitive to stau- 
rosporine treatment as those that did not express CrmA 
[18]. On the basis of these results, it was suggested that 
staurosporine-induced apoptosis does not depend on 
caspase-1 in Rat-1 or GM701 cells [18]. It is possible, 
however, that redundant caspase pathways exist in cells. 
By employing GTRCOS we have been able to show that 
indeed both caspase-1 and caspase-3 are activated on stau- 
rosporine treatment of Cos-7 cells and this activation was 
inhibited by the broad spectrum caspase inhibitor zVAD- 
fmk. These findings suggest that the FRET-based 
approach to measuring caspase activity is a more sensitive 
assay for caspase activation. 
The expression of fluorescent substratcs showed a 
uniform distribution in mammalian cells because of the 
lack of any specific organelle-targeting sequence. Vesicu- 
lar fluorescence was observed in 50% of mlfs- and mYfs- 
expressing cells, mostly localized in the cytoplasm 
(Figure 3c,d). At the moment we do not know the reason 
why such distinctive patterns of distribution are shown by 
these fluorescent substrate expressing cells. Experiments 
are underway to determine if the caspascs and their 
respective fluorescent substrates localize, resulting in the 
vesicular fluorescence pattern. Western analysis of mam- 
malian cells expressing mils or mYfs did not show a com- 
plete digestion of these 55 kDa substratcs into 27 kDa 
fragments (Figure 4a,b). These fluorescent substrates arc 
under the strong Cytomcgalovirus (CMV) promoter, 
which generates high levels of transcripts corresponding to
full-length fluorescent substrates in cells induced to 
undergo apoptosis. Such overwhelming amounts of sub- 
strate may not undergo complete digestion by newly acti- 
vated caspases, resulting in the presence of uncut, 
full-length substrates at any given time. 
The bands on the western blot of the cleavage of purified 
blfs and bYfs with caspase-1 and caspase-3 were smeared 
(Figure 2b). We observed that purified, blfs and bYfs are 
very stable in the Tris buffer in which they are eluted and 
stored (Figure 2a) but tend to show aberrant mobility 
when suspended in HEPES buffer (compare Figure 2a 
with 2b).These substrates are probably more stable in Tris 
buffer than in HEPES. 
GTRCOSs could be utilized for the study of spatial and/or 
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Measurement of caspase activity in vivo. Cos-7 cells expressing either 
mGfs, mYfs, mlfs, CFP or YFP were treated with staurosporin or 
mitomycin C for 8-10 h, and the extent of FRET of the caspase 
substrates was monitored. No change in FRET was seen in cells 
expressing CFP, YFP or mGfs. In Cos-7 cells expressing mYfs, both 
mitomycin C and staurosporin caused a decrease in the FRET signal, 
signifying cleavage. In mlfs-expressing cells only staurosporin caused 
activation of caspases. 
specific caspases and to determine the location of activity 
of caspases by targeting GTRCOSs to various cellular 
organelles. Large-scale production of GTRCOS by overex- 
pression in bacteria would help in identifying and design- 
ing inhibitors that are caspase specific or organelle specific. 
The strategy presented here has enabled us to determine 
the activation of specific caspases upon treatment of cells 
with different cell death stimuli. This method also 
demonstrated the activation of specific caspases in a single 
living cell, which has not yet been described. The method 
described here could be adapted to decipher the execu- 
tion pathway for various other apoptotic stimuli. 
Significance 
Apoptosis is a genetically regulated cellular suicide 
mechanism that plays a crucial role in development and 
in the defense against disease. One of the key regulators 
of mammalian apoptosis is the caspase family of pro- 
teases. Caspases are cysteine proteases haring a con- 
served active site that cleaves proteins at a highly specific 
site. Mammalian caspases now number 16 and can be 
subdivided into the ICE subfamily, caspase-2 subfamily 
and caspase-3 subfamily, each of which attack different 
cellular substrates. Caspases promote apoptosis through 
proteolytic degradation of cellular components, a process 
that involves autocatalysis of the caspases themselves. 
Defects in the caspase pathway are now known to 
underlie ischemic injury in stroke and neuronal degener- 
ation in amyotrophic lateral sclerosis, and are likely to 
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play a major role in the development and treatment of 
cancer. The finding that caspases play such a central 
role in these diseases is leading to the rapid development 
of drugs targeted to regulation of caspase activity. The 
assay described here will allow the screening, both at the 
single cell level and via high-throughput methods, of can- 
didate caspase inhibitors that could be applied clinically 
to modulate disease pathology. The caspase substrates 
described in this paper should allow stimuli and cell-type- 
dependent apoptotic pathways to be characterized. 
Materials and methods 
Construction of GFP-BFP fluorescent substrate expressing 
vectors 
The pS65T vector (Clontech) was digested with restriction enzymes 
Eco47111 and Xhol to release a 0.? kilobase DNA fragment correspond- 
ing to the GFP-coding region. The GFP-coding region was subcloned 
into pCAL-N prokaryotic expression vector (Stratagene) digested with 
restriction enzymes Smal and Xhol (termed as pNCG). The cDNA of 
BFP (kindly provided by Dr Roger Tsien) was amplified by the poly- 
merase chain reaction (PCR) with the following primers. For Yama sub- 
strates: (forward: 5'-ATG ACT CGA GCT GAT GAG GTA GAT GGC 
GGC ATG GGT AAA GGA GAA GAA CTT -3'; reverse: 5'-CAA AAG 
CR- CTA GGA CTT GTA TAG I-I-C ATC CAT GCC-3') containing 
Xhol and Hinolil restriction sites were used, whereas for ICE sub- 
strates, primers (forward: 5'-ATG ACT CGA GCT TAC GTC GCT 
GAT GGC GGC ATG GGT AAA GGA GAA GAA Cl-r -3'; reverse: 
5'-CAA AAG OFF CTA GGA CTT GTA TAG TTC ATC CAT GCC-3') 
with Xhol and Hin~ll restriction sites were used. All PCR amplifications 
were for 30 cycles (1st cycle, 5 min 94°C, 2 min 56°C, 3 min 72°C; 29 
cycles, 1 min 94°C, 2 min 55°C, 3 min 72°C; last cycle, 1 min 94°C, 
10 min 72°C) with Pfu polymerase (Stratagene). PCR products were 
digested with Xhol and Hine111 restriction enzymes and subcloned into 
pNCG vector digested with Xhol and Hina111, termed as pNCI (for ICE 
substrate, blfs) and pNCY (for Yama substrate, bYfs), respectively. 
Purification of (GFP-BFP) fluorescent substrates 
BL21(DE3) cells were transformed with pNCI and pNCY constructs 
followed by growth in 250 ml of LB broth with ampicillin and chloram- 
phenicol antibiotics. Cells were induced to express recombinant fluo- 
rescent substrates by addition of 1 mM of IPTG for 3 h followed by 
harvesting and lysis of cells in binding buffer (50 mM Tris, pH 8; 
150 mM NaCl; 10 mM ~-mercaptoethanol; 1 mM MgCI 2 and 1 mM 
CaCI2). Calmodulin affinity resin was suspended in binding buffer and 
bacterial cell lysate was added followed by incubation at 4°C for 2 h. 
Affinity resin was washed using ten volumes of binding buffer and 
eluted in ten volumes of elution buffer (50raM Tris, pH 8; 10 mM 
~-mercaptoethanol; 2 mM EGTA). Purified fluorescent substrates, blfs 
and bYfs were digested with purified caspase-1 and -3 in cleavage 
buffer (20 mM HEPES, pH 7.5 and 2 mM DTT) for 12-16 h at 37°C. 
Construction of (YFP-CFP) fluorescent substrate expressing 
vectors 
The cDNA of YFP (Packard) was amplified by PCR with the following 
primers: forward: 5'-TCC GCT AGC GCT ACC ATG CAC CAC CAC 
CAC CAC CAC ATG GTG AGC AAG GGC GAG GAG-3'; reverse: 
5'-TCG AGA TOT GAG TCC GGA Cl-r GTA CAG CTC GTC CAT 
GCC-3'). A 0.7 Kb PCR product was digested with Nhel and Bgl]l 
restriction enzymes and subcloned into the pS65T vector (Clontech) 
digested with restriction enzymes Nhel and Bglll (termed as pN'r). For 
the YAMA fluorescent substrate, a cDNA of CFP (kindly provided by R. 
Tsien) was amplified by PCR with the following primers: forward: 5'- 
ATG CAA GCT TOG GAT GAG GTA GAT GGC GGC ATG GTG 
AGC AAG GGC GAG GAG-3'; reverse: 5'-CAA GAA FrC "IqA C'IT 
GTA CAG CTC GTC CAT-3'), while for ICE substrates, primers were 
(forward: 5'- ATG CAA GCT TCG TAC GTC GCT GAT GGC GGC 
ATG GTG AGO AAG GGC GAG GAG-3'; reverse: 5'-CAA AAG CTT 
CTA GGA CIT GTA TAG FI-C ATC CAT GCC-3'). For the G4 fluores- 
cent substrate, the cDNA of CFP was PCR amplified using the follow- 
ing primers: forward: 5'-ATG CAA GCT TCG GGA GGA GGA GGA 
GGC GGC ATG GTG AGC AAG GGC GAG GAG-3'; reverse: 
5'-CAA GAA I-FC TTA CTT GTA CAG CTC GTC CAT-3'). PCR prod- 
ucts were eluted, digested with Hino111 and EcoRI restriction enzymes 
and subcloned into pNT vector digested with Hino111 and EcoRl. These 
constructs were termed as pNTYC for the YAMA substrate mYfs; 
pNTIC for the ICE substrate mlfs and pNTGC for the control fluores- 
cent substrate mGfs. 
Transfection of mammalian cells and western blotting 
Cos-7 cells were transfected transiently with various plasmid con- 
structs using Lipofectamine (Boerhinger Manheim). In six-well plates, 
2 x 105 cells per well were seeded on glass cover slips in appropriate 
growth medium and incubated at 37°C until cells were 60-70% con- 
fluent. DNA (2 rag) was added to 200 ml of growth medium lacking 
serum and antibiotics followed by addition of 1Oral lipofectamine 
reagent. This mixture was incubated at room temperature for 45 min 
and then 800 BI medium lacking serum and antibiotics were added. 
This DNA-lipofectamine mixture was added to cells and incubated for 
4 h at 37°C. Cells were rinsed with media containing serum and antibi- 
otics and fresh media was added followed by incubation for another 
24 h. The expression of various fusion proteins was confirmed by 
western blot analysis using anti-GFP monoclonal antibodies 
(Boehringer Mannheim). The cells were lysed and separated on 
10-200/o gradient SDS-PAGE. Proteins were transferred onto PVDF 
membrane and detected by using enhanced chemiluminiscence (ECL 
kit, Amersham). 
FRET quantitation 
For detection and quantitation of FRET due to GFP-BFP fluorescent 
substrates, the following filter sets were employed. For detection of 
GFP fluorescence, an excitation filter of 480/20 nm, a dichroic beam- 
spliter of 500 nm and an emission filter of 515/30 nm; for BFP fluores- 
cence, excitation filter of 390/20 nm, a dichroic beamsplitter of 420 nm 
and an emission filter of 450/40 nm and for FRET studies, excitation 
filter 390/20 nm, dichroic beamspliter 420 nm and an emission filter of 
515/30 nm. Purified protein (20 p.I) was taken on glass slide and cover 
slip was placed on it, followed by sealing with rubber cement. Slides 
were viewed under microscope and emission of photons per second 
was recorded using photon counter. As a control, bovine serum 
albumin was suspended in buffer and the photon emission was 
recorded. The emission of photons from buffer alone was used as 
background and was deducted from values obtained using blfs and 
bYfs substrates. 
Microscopy and image analysis 
Cells were treated with 5 pg/ml mitomycin c or 3.14BM of stau- 
rosporine for 12h. 50mM of zVAD-fmk or 10pM of DEVD- 
CHO/YVAD-CHO was used for inhibition of caspase activation. Cells 
were washed with phosphate buffered saline (PBS) and mounted on a 
glass slide in Vectashield mounting medium (Vector Labs). For detec- 
tion of CFP, cells were viewed with a filter set having an excitation filter 
of 425/40 nm, a dichroic beamspliter of 460 nm and an emission filter 
of 495/30 nm. YFP expression was detected by filter set having an 
excitation filter of 512/20 nm, a dichroic beamsplitter of 530 nm and an 
emission filter of 560/40 nm. The filter set combination used for FRET 
studies was: excitation filter 425/40 nm, dichroic beamspliter 460 nm 
and an emission filter of 560/40 nm. The images were captured using a 
slow-scan cooled COD camera (exposure 1.3-2 s) and were artificially 
colored using Adobe Photoshop. 
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